What are the major opportunities in the Hepatitis B Virus (HBV) market? What are the strategies for the Hepatitis B Virus (HBV) market?

For detailed insights on the major opportunities and strategies in the Hepatitis B Virus (HBV) market, Read More

How does the Hepatitis B Virus (HBV) market relate to the overall economy and other similar markets?

For detailed insights on Hepatitis B Virus (HBV)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Hepatitis B Virus (HBV) market growth? SWOT analysis of the Hepatitis B Virus (HBV) market.

For detailed insights on the key dynamics influencing the Hepatitis B Virus (HBV) market growth and SWOT analysis of the Hepatitis B Virus (HBV) industry, Read More

Global Hepatitis B Virus (HBV) Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Hepatitis B Virus (HBV) Global Market Report 2025

Name: Hepatitis B Virus (HBV) Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Acute, Chronic), By Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery), By Age Group (Pediatrics, Adults, Seniors), By End User (Medical Providers, Patients, Healthcare Payers) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Hepatitis B Virus (HBV) Market Overview

• Hepatitis B Virus (HBV) market size has reached to $6.71 billion in 2024

• Expected to grow to $10.59 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%

• Growth Driver: Rising Hepatitis B Infection Rates Fuel Growth Prospects For Hepatitis B Virus Market

• Market Trend: Rising Emphasis On Highly Sensitive Hbsag Test Revolutionizes Hepatitis B Virus (HBV) Detection And Treatment

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hepatitis B Virus (HBV) Market?

Hepatitis B virus (HBV) is a viral infection targeting the liver, transmitted via exposure to contaminated blood or bodily fluids or vertical transmission from mother to child during childbirth. Treatment involves antiviral medications to suppress viral replication, with vaccination being a crucial preventive measure.

The main types of hepatitis B virus (HBV) are Acute and Chronic. Acute hepatitis B refers to a short-term infection caused by the hepatitis B virus that occurs within the first six months of exposure to the virus and the medications aim to clear the virus from the body and prevent chronic infection. They are treated with immune modulator drugs, antiviral drugs, vaccines, and surgery for different age groups, such as pediatrics, adults, and seniors, by medical providers, patients, and healthcare payers.

Hepatitis B Virus (HBV) Market Size and growth rate 2025 to 2029: Graph

What Is The Hepatitis B Virus (HBV) Market Size 2025 And Growth Rate?

What Is The Hepatitis B Virus (HBV) Market Growth Forecast?

The hepatitis B virus (HBV) market size is expected to see strong growth in the next few years. It will grow to $10.59 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rise of personalized medicine, growing support from patient advocacy groups, rising vaccination programs, increase in healthcare expenditure. Major trends in the forecast period include development of new drugs, advancements in diagnostic technologies, public-private partnerships, innovative biological therapies.

The forecast of 9.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade restrictions could hinder U.S. viral hepatitis monitoring by inflating prices of hepatitis b virus deoxyribonucleic acid quantitative polymerase chain reaction tests and liver elastography equipment sourced from France and Singapore, delaying chronic hepatitis B management and raising hepatology clinic costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Hepatitis B Virus (HBV) Market Segmented?

1) By Type: Acute, Chronic

2) By Treatment: Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery

3) By Age Group: Pediatrics, Adults, Seniors

4) By End User: Medical Providers, Patients, Healthcare Payers

Subsegments:

1) By Acute HBV: Asymptomatic Acute HBV, Symptomatic Acute HBV, Severe Acute HBV

2) By Chronic HBV: Chronic Hepatitis B (HBeAg Positive), Chronic Hepatitis B (HBeAg Negative), Chronic Hepatitis B With Compensated Liver Disease, Chronic Hepatitis B With Decompensated Liver Disease, Chronic Hepatitis B With Hepatocellular Carcinoma (HCC)

What Is Driving The Hepatitis B Virus (HBV) Market? Rising Hepatitis B Infection Rates Fuel Growth Prospects For Hepatitis B Virus Market

The high prevalence of hepatitis B infection is expected to propel the growth of the hepatitis B virus market going forward. Hepatitis B is a liver infection brought on by the hepatitis B virus (HBV), which is prevented through vaccination. Rising hepatitis B infection rates can increase demand for diagnostic tests and treatment options. For instance, in April 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in 2022, 254 million people were affected by chronic hepatitis B, with 1.2 million new cases occurring annually. Therefore, the high prevalence of hepatitis B infection will drive the hepatitis B virus market.

What Is Driving The Hepatitis B Virus (HBV) Market? Rising Incidences of Liver Damage and Cirrhosis Fuel Growth in Hepatitis B Virus Market

An increase in the incidences of patients with liver damage or cirrhosis is expected to propel the growth of the hepatitis B virus market going forward. Cirrhosis is a severe form of liver disease in which scar tissue permanently replaces good liver tissue. Hepatitis B virus Impact patient's kidney function while alleviating symptoms and adverse effects of the disorder. For instance, in July 2023, according to Office for Health Improvement and Disparities, a UK-based department of health and social care, in the financial year ending 2022, England recorded 82,290 hospital admissions due to liver disease, which corresponds to a rate of 150.6 per 100,000 people. This represents an increase from the 67,458 admissions observed in the previous financial year ending 2021. The rise highlights a growing concern regarding liver health in the population. Therefore, the increase in the incidences of patients with liver damage or cirrhosis is driving the growth of the Hepatitis B virus market.

Who Are The Major Players In The Global Hepatitis B Virus (HBV) Market?

Major companies operating in the hepatitis B virus (HBV) market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmon La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Eisai Co. Ltd., Aurobindo Pharma Limited, Apotex Corp., Lupin Pharmaceuticals Inc., Cadila Healthcare Ltd., Celltrion Inc., Dynavax Technologies Corporation, Accord Healthcare Inc., Par Pharmaceutical Inc., Arrowhead Pharmaceuticals Inc., Arbutus Biopharma Corporation, Globeimmune Inc., Antios Therapeutics Inc.

What Are The Key Trends Of The Global Hepatitis B Virus (HBV) Market? Rising Emphasis On Highly Sensitive Hbsag Test Revolutionizes Hepatitis B Virus (HBV) Detection And Treatment

Major companies operating in the hepatitis B virus (HBV) market are focused on the development of advanced diagnostics and treatment options such as the use of highly sensitive chemiluminescent microparticle immunoassay (CMIA) to gain competitive advantages in the market. For instance, in May 2022, Abbott Laboratories, a US-based healthcare company, launched the HBsAg Next Qualitative Solution Test, which will aid in the early detection of Hepatitis B virus (HBV) in human serum and plasma samples and improve patient outcomes while preserving safe blood supplies. The early and improved detection of HBV in human serum and plasma (blood) samples, as well as population screening, are made possible by this highly sensitive chemiluminescent microparticle immunoassay (CMIA).

Need data on a specific region in this market?

Request Customisation

What Are Latest Mergers And Acquisitions In The Hepatitis B Virus (HBV) Market? Brii Biosciences Acquires Licensing Rights For Hepatitis B Immunotherapy And Vaccine From Vbi Vaccines Inc

In July 2023, Brii Biosciences Ltd., a China-based biotechnology company, acquired licensing rights for an experimental hepatitis B immunotherapy and an approved hepatitis B vaccine from VBI Vaccines Inc. for an undisclosed amount. With this acquisition, Brii Biosciences Ltd. will have access to information on the prevention and treatment of the disease. VBI Vaccines Inc. is a US-based biotechnology company engaged in developing a vaccine to prevent infection caused by the hepatitis B virus.

Regional Outlook For The Global Hepatitis B Virus (HBV) Market

North America was the largest region in the hepatitis B Virus (HBV) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hepatitis B Virus (HBV) Market?

The hepatitis B virus (HBV) market consists of revenues earned by entities by providing diagnostic testing for infection and monitoring of liver function. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis B virus (HBV) market also includes sales of tenofovir disoproxil, entecavir, telbivudine and lamivudine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Hepatitis B Virus (HBV) Industry?

The hepatitis b virus (hbv) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hepatitis b virus (hbv) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Hepatitis B Virus (HBV) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$7.31 billion
Revenue Forecast In 2034	$10.59 billion
Growth Rate	CAGR of 9.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Acute, Chronic 2) By Treatment: Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery 3) By Age Group: Pediatrics, Adults, Seniors 4) By End User: Medical Providers, Patients, Healthcare Payers Subsegments: 1) By Acute HBV: Asymptomatic Acute HBV, Symptomatic Acute HBV, Severe Acute HBV 2) By Chronic HBV: Chronic Hepatitis B (HBeAg Positive), Chronic Hepatitis B (HBeAg Negative), Chronic Hepatitis B With Compensated Liver Disease, Chronic Hepatitis B With Decompensated Liver Disease, Chronic Hepatitis B With Hepatocellular Carcinoma (HCC)
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmon La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Eisai Co. Ltd., Aurobindo Pharma Limited, Apotex Corp., Lupin Pharmaceuticals Inc., Cadila Healthcare Ltd., Celltrion Inc., Dynavax Technologies Corporation, Accord Healthcare Inc., Par Pharmaceutical Inc., Arrowhead Pharmaceuticals Inc., Arbutus Biopharma Corporation, Globeimmune Inc., Antios Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Hepatitis B Virus (HBV) Market Characteristics

3. Hepatitis B Virus (HBV) Market Trends And Strategies

4. Hepatitis B Virus (HBV) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hepatitis B Virus (HBV) Growth Analysis And Strategic Analysis Framework

5.1. Global Hepatitis B Virus (HBV) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Hepatitis B Virus (HBV) Market Growth Rate Analysis

5.4. Global Hepatitis B Virus (HBV) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Hepatitis B Virus (HBV) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Hepatitis B Virus (HBV) Total Addressable Market (TAM)

6. Hepatitis B Virus (HBV) Market Segmentation

6.1. Global Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute

Chronic

6.2. Global Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immune Modulator Drugs

Antiviral Drugs

Vaccine

Surgery

6.3. Global Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatrics

Adults

Seniors

6.4. Global Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medical Providers

Patients

Healthcare Payers

6.5. Global Hepatitis B Virus (HBV) Market, Sub-Segmentation Of Acute HBV, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Asymptomatic Acute HBV

Symptomatic Acute HBV

Severe Acute HBV

6.6. Global Hepatitis B Virus (HBV) Market, Sub-Segmentation Of Chronic HBV, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Hepatitis B (HBeAg Positive)

Chronic Hepatitis B (HBeAg Negative)

Chronic Hepatitis B With Compensated Liver Disease

Chronic Hepatitis B With Decompensated Liver Disease

Chronic Hepatitis B With Hepatocellular Carcinoma (HCC)

7. Hepatitis B Virus (HBV) Market Regional And Country Analysis

7.1. Global Hepatitis B Virus (HBV) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Hepatitis B Virus (HBV) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hepatitis B Virus (HBV) Market

8.1. Asia-Pacific Hepatitis B Virus (HBV) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hepatitis B Virus (HBV) Market

9.1. China Hepatitis B Virus (HBV) Market Overview

9.2. China Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hepatitis B Virus (HBV) Market

10.1. India Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hepatitis B Virus (HBV) Market

11.1. Japan Hepatitis B Virus (HBV) Market Overview

11.2. Japan Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hepatitis B Virus (HBV) Market

12.1. Australia Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hepatitis B Virus (HBV) Market

13.1. Indonesia Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hepatitis B Virus (HBV) Market

14.1. South Korea Hepatitis B Virus (HBV) Market Overview

14.2. South Korea Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hepatitis B Virus (HBV) Market

15.1. Western Europe Hepatitis B Virus (HBV) Market Overview

15.2. Western Europe Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hepatitis B Virus (HBV) Market

16.1. UK Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hepatitis B Virus (HBV) Market

17.1. Germany Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hepatitis B Virus (HBV) Market

18.1. France Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hepatitis B Virus (HBV) Market

19.1. Italy Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hepatitis B Virus (HBV) Market

20.1. Spain Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hepatitis B Virus (HBV) Market

21.1. Eastern Europe Hepatitis B Virus (HBV) Market Overview

21.2. Eastern Europe Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hepatitis B Virus (HBV) Market

22.1. Russia Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hepatitis B Virus (HBV) Market

23.1. North America Hepatitis B Virus (HBV) Market Overview

23.2. North America Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hepatitis B Virus (HBV) Market

24.1. USA Hepatitis B Virus (HBV) Market Overview

24.2. USA Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hepatitis B Virus (HBV) Market

25.1. Canada Hepatitis B Virus (HBV) Market Overview

25.2. Canada Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hepatitis B Virus (HBV) Market

26.1. South America Hepatitis B Virus (HBV) Market Overview

26.2. South America Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hepatitis B Virus (HBV) Market

27.1. Brazil Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hepatitis B Virus (HBV) Market

28.1. Middle East Hepatitis B Virus (HBV) Market Overview

28.2. Middle East Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hepatitis B Virus (HBV) Market

29.1. Africa Hepatitis B Virus (HBV) Market Overview

29.2. Africa Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hepatitis B Virus (HBV) Market Competitive Landscape And Company Profiles

30.1. Hepatitis B Virus (HBV) Market Competitive Landscape

30.2. Hepatitis B Virus (HBV) Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmon La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hepatitis B Virus (HBV) Market Other Major And Innovative Companies

31.1. Bayer AG

31.2. Bristol-Myers Squibb Company

31.3. AstraZeneca PLC

31.4. Sanofi SA

31.5. GlaxoSmithKline PLC

31.6. Takeda Pharmaceutical Company Limited

31.7. Eli Lilly and Company

31.8. Gilead Sciences Inc.

31.9. Boehringer Ingelheim International GmbH

31.10. Mylan N.V.

31.11. Teva Pharmaceutical Industries Ltd.

31.12. Vertex Pharmaceuticals Incorporated

31.13. Eisai Co. Ltd.

31.14. Aurobindo Pharma Limited

31.15. Apotex Corp.

32. Global Hepatitis B Virus (HBV) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hepatitis B Virus (HBV) Market

34. Recent Developments In The Hepatitis B Virus (HBV) Market

35. Hepatitis B Virus (HBV) Market High Potential Countries, Segments and Strategies

35.1 Hepatitis B Virus (HBV) Market In 2029 - Countries Offering Most New Opportunities

35.2 Hepatitis B Virus (HBV) Market In 2029 - Segments Offering Most New Opportunities

35.3 Hepatitis B Virus (HBV) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Hepatitis B Virus (HBV) Market, Sub-Segmentation Of Acute HBV, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Hepatitis B Virus (HBV) Market, Sub-Segmentation Of Chronic HBV, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Hepatitis B Virus (HBV) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Hepatitis B Virus (HBV) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Pfizer Inc. Financial Performance

Table 78: Johnson & Johnson Services Inc. Financial Performance

Table 79: F. Hoffmon La Roche Ltd. Financial Performance

Table 80: Merck & Co. Inc. Financial Performance

Table 81: AbbVie Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Hepatitis B Virus (HBV) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Hepatitis B Virus (HBV) Market, Sub-Segmentation Of Acute HBV, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Hepatitis B Virus (HBV) Market, Sub-Segmentation Of Chronic HBV, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Hepatitis B Virus (HBV) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Hepatitis B Virus (HBV) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Hepatitis B Virus (HBV) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Hepatitis B Virus (HBV) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Hepatitis B Virus (HBV) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Pfizer Inc. Financial Performance

Figure 78: Johnson & Johnson Services Inc. Financial Performance

Figure 79: F. Hoffmon La Roche Ltd. Financial Performance

Figure 80: Merck & Co. Inc. Financial Performance

Figure 81: AbbVie Inc. Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Factoring Market 2023 – By Type (Recourse, Non-Recourse), By Organization Size (Small And Medium Enterprises, Large Enterprises), By Category (International, Domestic), By Application (Transportation, Healthcare, Constru...

View Report

Microcarrier Global Market Report 2025 – By Product (Equipment, Consumables), By Type (Cationic Microcarriers, Collagen-Coated Microcarriers, Protein-Coated Microcarriers, Untreated Microcarriers, Other Microcarriers), B...

View Report

Air Defense System Global Market Report 2025 – By Type (Missile Defense System, Anti-Aircraft System, Counter Rocket, Artillery And Mortar (C-RAM) System), By Component (Weapon System, Fire Control System, Command And Co...

View Report

Recreation Clubs Global Market Report 2025 – By Category (Recreational Sports Clubs, Non-Sports Recreational Clubs), By Age Group (Baby Boomers, Generation X, Millennials, Generation Z), By Travelers Type (Solo, Group) –...

View Report

Cardiac Safety Services Global Market Report 2025 – By Services (ECG Or Holter Measurements, Blood Pressure Measurements, In Vitro Cardiac Safety Assessment Services, Cardiovascular Imaging, Real-Time Telemetry Monitorin...

View Report

Plant-Based Vaccines Global Market Report 2025 – By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Application (Infl...

View Report

Preclinical Assets Global Market Report 2025 – By Service (Bioanalysis And DMPK (Drug Metabolism and Pharmacokinetic) studies, Toxicology Testing, Compound Management, Safety Pharmacology, Other Services), By Model Type ...

View Report

Frequently Asked Questions

What is the definition of the Hepatitis B Virus (HBV) market?

How will the Hepatitis B Virus (HBV) market drivers and restraints affect the market dynamics? What forces will shape the Hepatitis B Virus (HBV) industry going forward?

The market major growth driver - Rising Hepatitis B Infection Rates Fuel Growth Prospects For Hepatitis B Virus Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Hepatitis B Virus (HBV) market?

The hepatitis B virus (HBV) market size has grown strongly in recent years. It will grow from $6.71 billion in 2024 to $7.31 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising prevalence of hepatitis b virus (hbv), growing demand for hbv diagnostics, expanding hbv vaccine coverage, rising awareness of hepatitis b virus (hbv). The hepatitis B virus (HBV) market size is expected to see strong growth in the next few years. It will grow to " $10.59 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rise of personalized medicine, growing support from patient advocacy groups, rising vaccination programs, increase in healthcare expenditure. Major trends in the forecast period include development of new drugs, advancements in diagnostic technologies, public-private partnerships, innovative biological therapies. For further insights on this market, request a sample here

How is the Hepatitis B Virus (HBV) market segmented?

The hepatitis b virus (hbv) market covered in this report is segmented –
1) By Type: Acute, Chronic
2) By Treatment: Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery
3) By Age Group: Pediatrics, Adults, Seniors
4) By End User: Medical Providers, Patients, Healthcare Payers Subsegments:
1) By Acute HBV: Asymptomatic Acute HBV, Symptomatic Acute HBV, Severe Acute HBV
2) By Chronic HBV: Chronic Hepatitis B (HBeAg Positive), Chronic Hepatitis B (HBeAg Negative), Chronic Hepatitis B With Compensated Liver Disease, Chronic Hepatitis B With Decompensated Liver Disease, Chronic Hepatitis B With Hepatocellular Carcinoma (HCC) For further insights on this market, request a sample here

Which region has the largest share of the Hepatitis B Virus (HBV) market? What are the other regions covered in the report?

North America was the largest region in the hepatitis B Virus (HBV) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hepatitis B virus (HBV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the Hepatitis B Virus (HBV) market?

Major companies operating in the hepatitis b virus (hbv) market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmon La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Eisai Co. Ltd., Aurobindo Pharma Limited, Apotex Corp., Lupin Pharmaceuticals Inc., Cadila Healthcare Ltd., Celltrion Inc., Dynavax Technologies Corporation, Accord Healthcare Inc., Par Pharmaceutical Inc., Arrowhead Pharmaceuticals Inc., Arbutus Biopharma Corporation, Globeimmune Inc., Antios Therapeutics Inc.. For further insights on this market, request a sample here.

What are the key trends in the Hepatitis B Virus (HBV) market?

Major trends in this market include Rising Emphasis On Highly Sensitive Hbsag Test Revolutionizes Hepatitis B Virus (HBV) Detection And Treatment. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Hepatitis B Virus (HBV) Global Market Report 2025

By Type (Acute, Chronic), By Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery), By Age Group (Pediatrics, Adults, Seniors), By End User (Medical Providers, Patients, Healthcare Payers) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Hepatitis B Virus (HBV) Market Overview

What Is Covered Under Hepatitis B Virus (HBV) Market?

What Is The Hepatitis B Virus (HBV) Market Size 2025 And Growth Rate?

What Is The Hepatitis B Virus (HBV) Market Growth Forecast?

What’s The Trade War Impact On Pharmaceuticals Industry?

How Is The Hepatitis B Virus (HBV) Market Segmented?

What Is Driving The Hepatitis B Virus (HBV) Market? Rising Hepatitis B Infection Rates Fuel Growth Prospects For Hepatitis B Virus Market

What Is Driving The Hepatitis B Virus (HBV) Market? Rising Incidences of Liver Damage and Cirrhosis Fuel Growth in Hepatitis B Virus Market

Who Are The Major Players In The Global Hepatitis B Virus (HBV) Market?

What Are The Key Trends Of The Global Hepatitis B Virus (HBV) Market? Rising Emphasis On Highly Sensitive Hbsag Test Revolutionizes Hepatitis B Virus (HBV) Detection And Treatment

What Are Latest Mergers And Acquisitions In The Hepatitis B Virus (HBV) Market? Brii Biosciences Acquires Licensing Rights For Hepatitis B Immunotherapy And Vaccine From Vbi Vaccines Inc

Regional Outlook For The Global Hepatitis B Virus (HBV) Market

What Defines the Hepatitis B Virus (HBV) Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Hepatitis B Virus (HBV) Industry?

Hepatitis B Virus (HBV) Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions